Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
Journal
Annals of Oncology
Journal Volume
32
Journal Issue
12
Pages
1496-1510
Date Issued
2021
Author(s)
Yoshino T.
Argil?s G.
Oki E.
Martinelli E.
Taniguchi H.
Arnold D.
Mishima S.
Li Y.
Smruti B.K.
Ahn J.B.
Faud I.
Chee C.E.
Lin P.-C.
Chua C.
Hasbullah H.H.
Lee M.A.
Sharma A.
Sun Y.
Curigliano G.
Bando H.
Lordick F.
Yamanaka T.
Tabernero J.
Baba E.
Cervantes A.
Ohtsu A.
Peters S.
Ishioka C.
Pentheroudakis G.
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of localised colon cancer was published in 2020. It was decided by both the ESMO and the Japanese Society of Medical Oncology (JSMO) to convene a special virtual guidelines meeting in March 2021 to adapt the ESMO 2020 guidelines to take into account the ethnic differences associated with the treatment of localised colon cancer in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with localised colon cancer representing the oncological societies of Japan (JSMO), China (CSCO), India (ISMPO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug availability and reimbursement situations in the different Asian countries. ? 2021
Subjects
diagnosis; ESMO; guidelines; localised colon cancer; Pan-Asian; treatment
SDGs
Other Subjects
capecitabine plus oxaliplatin; fluoropyrimidine; fluorouracil; folinate calcium; oxaliplatin; Article; Asian; cancer diagnosis; cancer staging; cancer therapy; China; colon cancer; colon resection; colonoscopy; consensus; disease risk assessment; endoscopic surgery; ethnic difference; European Society for Medical Oncology; follow up; genetic profile; human; India; Japan; Korea; Malaysia; medical society; occult blood test; practice guideline; reimbursement; Singapore; Taiwan; Asia; colon tumor; epidemiology; follow up; oncology; practice guideline; South Korea; Asia; Colonic Neoplasms; Follow-Up Studies; Humans; Medical Oncology; Republic of Korea
Publisher
Elsevier Ltd
Type
journal article